These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 12806951

  • 1. [Malignancy-associated hypercalcemia].
    Oura S.
    Nihon Rinsho; 2003 Jun; 61(6):1006-9. PubMed ID: 12806951
    [Abstract] [Full Text] [Related]

  • 2. [Treatment of malignancy associated hypercalcemia].
    Tai N, Inoue D.
    Clin Calcium; 2014 Aug; 24(8):1223-8. PubMed ID: 25065875
    [Abstract] [Full Text] [Related]

  • 3. [Medical treatment of malignant hypercalcemia].
    Eto S, Nakano Y, Okada Y.
    Gan To Kagaku Ryoho; 1993 Dec; 20(15):2311-8. PubMed ID: 8259844
    [Abstract] [Full Text] [Related]

  • 4. [Bone and calcium metabolism associated with malignancy. Malignancy-associated hypercalcemia.].
    Tai N, Inoue D.
    Clin Calcium; 2018 Dec; 28(11):1503-1508. PubMed ID: 30374007
    [Abstract] [Full Text] [Related]

  • 5. [Treatment of malignancy-associated hypercalcemia].
    Endo I, Inoue D.
    Clin Calcium; 2006 Apr; 16(4):665-69. PubMed ID: 16582519
    [Abstract] [Full Text] [Related]

  • 6. Bisphosphonates for cancer patients: why, how, and when?
    Body JJ, Mancini I.
    Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
    [Abstract] [Full Text] [Related]

  • 7. Hypercalcemic complication in patients with oral squamous cell carcinoma.
    Iwase M, Takemi T, Manabe M, Nagumo M.
    Int J Oral Maxillofac Surg; 2003 Apr; 32(2):174-80. PubMed ID: 12729778
    [Abstract] [Full Text] [Related]

  • 8. Hypercalcemia and bone resorption in malignancy.
    Walls J, Bundred N, Howell A.
    Clin Orthop Relat Res; 1995 Mar; (312):51-63. PubMed ID: 7634618
    [Abstract] [Full Text] [Related]

  • 9. [Therapeutic possibilities in paraneoplastic hypercalcemia].
    Schürer CC, Peters U, Fischer JT.
    Med Welt; 1981 Aug 14; 32(32-33):1219-21. PubMed ID: 6456397
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Bisphosphonate treatment of bone metastases and hypercalcemia of malignancy.
    Coleman RE.
    Oncology (Williston Park); 1991 Aug 14; 5(8):55-60; discussion 60-2, 65. PubMed ID: 1834153
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Combination of calcitonin and pamidronate for emergency treatment of malignant hypercalcemia.
    Sekine M, Takami H.
    Oncol Rep; 1998 Aug 14; 5(1):197-9. PubMed ID: 9458321
    [Abstract] [Full Text] [Related]

  • 18. Drug therapy of hypercalcemia due to malignancy.
    Raue F, Pecherstorfer M.
    Recent Results Cancer Res; 1994 Aug 14; 137():138-60. PubMed ID: 7878293
    [No Abstract] [Full Text] [Related]

  • 19. Bisphosphonates and primary hyperparathyroidism.
    Rodan GA.
    J Bone Miner Res; 2002 Nov 14; 17 Suppl 2():N150-3. PubMed ID: 12412793
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.